about
Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseasesTurning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and PainClinical correlates of common corneal neovascular diseases: a literature reviewAssociation of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytesDistinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitisCorneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCδ).In vitro effect of a corrosive hostile ocular surface on candidate biomaterials for keratoprosthesis skirt.Pathophysiology of ocular surface squamous neoplasiaPrevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.Antimicrobial susceptibility and minimal inhibitory concentration of Pseudomonas aeruginosa isolated from septic ocular surface disease in different animal species.Toll-like receptors in ocular surface diseases: overview and new findings.Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.Ocular Surface as Barrier of Innate Immunity.Ocular Involvement in Systemic Autoimmune Diseases.The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.Limbal epithelial stem-microenvironmental alteration leads to pterygium development.Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years.Tacrolimus downregulates inflammation by regulating pro‑/anti‑inflammatory responses in LPS‑induced keratitis.Patients' Perceptions of Trichiasis Surgery: Results from the Partnership for Rapid Elimination of Trachoma (PRET) Surgery Clinical Trial.Distribution and Diversity of Ocular Microbial Communities in Diabetic Patients Compared with Healthy Subjects.Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues.Diagnosis and Management of Conjunctivitis for the Dermatologist.The utilization of an ocular wound chamber on corneal epithelial wounds.
P2860
Q26849739-41D45E55-CE18-4D5A-930B-3328187071C6Q28066928-FC9229FE-DDB7-4297-AA56-F24992334574Q28257676-1EAA21A9-9F55-4D2D-9434-8CBD22400F47Q33497628-92E322B6-3B1E-4557-B7CF-F2EA3E063667Q33628773-5AC062F9-B009-4ED3-A290-F88EDF4E0B05Q34020741-ED70BA1B-CDDA-418C-A61C-A7DDC2BE00E0Q36204331-B512464A-1E72-4AD1-9ECE-8EA9502DF491Q36501666-8D072921-1EC2-4391-BA62-1702F8FA35C1Q36991724-105B671A-E95C-4320-8F93-A301D49C6DE2Q37463976-BE30757D-DA6F-40B0-AFEB-FE3F1007C5BAQ37832747-DCAFF069-C001-41D8-99F6-EF891D22F6B3Q38138170-4AEF452B-EE2F-43FA-A96F-6027982F2816Q38544776-3BE439A2-DC01-4F4B-B048-897985533898Q38614543-A70AF324-D0E1-47BE-9CD1-0D5AA150A0BDQ38650844-54F4A155-6263-44EC-B84E-C0064EEB982AQ38962402-C1749E39-3F65-4DCC-893C-37B4EBFB69B0Q39580721-7ADA5529-C506-4B72-8423-D7C8AE5A1C18Q40076461-20618058-4DC5-4FB4-8D20-16FFA8D3A05CQ41590389-33960DD7-1CC5-4049-8F50-BF6D3C0EC698Q46254747-756F22CF-4A09-4F3A-B7E1-C90244ED7A8AQ47316408-514F1495-39A2-48EB-8F71-899A4412CCD7Q49483779-EA3769B2-9237-45B2-AE25-044919FE440DQ55220654-098AAD87-C969-4BC0-9193-B6C0C98521C4
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Immune defense at the ocular surface.
@ast
Immune defense at the ocular surface.
@en
type
label
Immune defense at the ocular surface.
@ast
Immune defense at the ocular surface.
@en
prefLabel
Immune defense at the ocular surface.
@ast
Immune defense at the ocular surface.
@en
P2860
P356
P1433
P1476
Immune defense at the ocular surface.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.EYE.6700617
P577
2003-11-01T00:00:00Z